Search Results - "Fongaro, Benedetta"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC by Palazzi, Luana, Fongaro, Benedetta, Leri, Manuela, Acquasaliente, Laura, Stefani, Massimo, Bucciantini, Monica, Polverino de Laureto, Patrizia

    “…The interplay between α-synuclein and dopamine derivatives is associated with oxidative stress-dependent neurodegeneration in Parkinson’s disease (PD). The…”
    Get full text
    Journal Article Web Resource
  2. 2
  3. 3

    Environmental Signals Act as a Driving Force for Metabolic and Defense Responses in the Antarctic Plant Colobanthus quitensis by Bertini, Laura, Proietti, Silvia, Fongaro, Benedetta, Holfeld, Aleš, Picotti, Paola, Falconieri, Gaia Salvatore, Bizzarri, Elisabetta, Capaldi, Gloria, Polverino de Laureto, Patrizia, Caruso, Carla

    Published in Plants (Basel) (21-11-2022)
    “…During evolution, plants have faced countless stresses of both biotic and abiotic nature developing very effective mechanisms able to perceive and counteract…”
    Get full text
    Journal Article Web Resource
  4. 4
  5. 5

    Light exacerbates local and global effects induced by pH unfolding of Ipilimumab by Rizzotto, Elena, Inciardi, Ilenia, Fongaro, Benedetta, Trolese, Philipp, Miolo, Giorgia, Polverino de Laureto, Patrizia

    “…[Display omitted] Monoclonal antibodies (mAbs) are an essential class of therapeutic proteins for the treatment of cancer, autoimmune and rare diseases. During…”
    Get full text
    Journal Article
  6. 6

    Managing antibody stability: Effects of stressors on Ipilimumab from the commercial formulation to diluted solutions by Fongaro, Benedetta, Cian, Valentina, Gabaldo, Francesca, De Paoli, Giorgia, Miolo, Giorgia, Polverino de Laureto, Patrizia

    “…[Display omitted] The stability of the monoclonal antibody Ipilimumab, the active ingredient of Yervoy®, used for the treatment of different types of cancer,…”
    Get full text
    Journal Article Web Resource
  7. 7

    Catechol-induced covalent modifications modulate the aggregation tendency of α-synuclein: An in-solution and in-silico study by Inciardi, Ilenia, Rizzotto, Elena, Gregoris, Francesco, Fongaro, Benedetta, Sosic, Alice, Minervini, Giovanni, Polverino de Laureto, Patrizia

    Published in BioFactors (Oxford) (27-05-2024)
    “…Parkinson's disease (PD) stands as a challenging neurodegenerative condition characterized by the emergence of Lewy Bodies (LBs), intracellular inclusions…”
    Get full text
    Journal Article
  8. 8

    3,4‐Dihydroxyphenylethanol and 3,4‐dihydroxyphenylacetic acid affect the aggregation process of E46K variant of α‐synuclein at different extent: Insights into the interplay between protein dynamics and catechol effect by Fongaro, Benedetta, Cappelletto, Elia, Sosic, Alice, Spolaore, Barbara, Polverino de Laureto, Patrizia

    Published in Protein science (01-07-2022)
    “…Parkinson's disease (PD) is a chronic multifactorial disease, whose etiology is not completely understood. The amyloid aggregation of α‐synuclein (Syn) is…”
    Get full text
    Journal Article Web Resource
  9. 9

    Assessing the physicochemical stability and intracellular trafficking of mRNA-based COVID-19 vaccines by Fongaro, Benedetta, Campara, Benedetta, Moscatiello, Giulia Yuri, De Luigi, Ada, Panzeri, Davide, Sironi, Laura, Bigini, Paolo, Carretta, Giovanni, Miolo, Giorgia, Pasut, Gianfranco, Polverino De Laureto, Patrizia

    Published in International journal of pharmaceutics (25-09-2023)
    “…[Display omitted] The emergence of SARS-CoV-2 in Wuhan, China in 2019 has had a profound impact on humanity in every facet. While vaccines against this viral…”
    Get full text
    Journal Article
  10. 10
  11. 11